trial · primary record
ISM5411 tablets
Ulcerative Colitis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 80 |
| Primary completion | 2027-08-30 |
| Primary endpoint | The rate of treatment-emergent adverse events (TEAEs) in each group. |
| Registry ID | NCT07265570 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:57.507Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07265570
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.